CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,631,000 | -596,000 | 6,623,000 | 5,319,000 | 5,239,000 |
| Depreciation Amortization | 4,371,000 | 8,867,000 | 2,660,000 | 2,475,000 | 2,092,000 |
| Income taxes - deferred | -654,000 | 87,000 | -1,334,000 | 18,000 | -252,000 |
| Accounts receivable | -2,158,000 | -1,139,000 | -941,000 | -243,000 | -1,594,000 |
| Accounts payable and accrued liabilities | 3,550,000 | 2,329,000 | 1,710,000 | 2,189,000 | 2,834,000 |
| Other Working Capital | 1,499,000 | -112,000 | -416,000 | 1,329,000 | 1,244,000 |
| Other Operating Activity | -391,000 | -571,000 | -295,000 | -946,000 | -1,024,000 |
| Operating Cash Flow | $12,848,000 | $8,865,000 | $8,007,000 | $10,141,000 | $8,539,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,534,000 | N/A | N/A | -80,000 | -267,000 |
| PPE Investments | -2,457,000 | -2,037,000 | -1,918,000 | -2,224,000 | -2,332,000 |
| Net Acquisitions | -444,000 | -41,394,000 | -1,181,000 | -524,000 | -11,475,000 |
| Purchase Of Investment | N/A | -692,000 | -137,000 | N/A | N/A |
| Sale Of Investment | 7,049,000 | 817,000 | 61,000 | 91,000 | 243,000 |
| Other Investing Activity | 47,000 | 21,000 | 298,000 | 267,000 | 411,000 |
| Investing Cash Flow | $-3,339,000 | $-43,285,000 | $-2,877,000 | $-2,470,000 | $-13,420,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,874,000 | -685,000 |
| Debt Issued | 3,736,000 | 44,343,000 | 0 | 3,455,000 | 14,805,000 |
| Debt Repayment | -8,336,000 | -5,522,000 | 0 | -5,943,000 | -2,902,000 |
| Common Stock Issued | 210,000 | 242,000 | 329,000 | 296,000 | 362,000 |
| Common Stock Repurchased | N/A | N/A | -4,361,000 | -4,461,000 | -5,001,000 |
| Dividend Paid | -2,603,000 | -2,038,000 | -2,049,000 | -1,840,000 | -1,576,000 |
| Other Financing Activity | -661,000 | -206,000 | -670,000 | -142,000 | -124,000 |
| Financing Cash Flow | $-7,654,000 | $36,819,000 | $-6,751,000 | $-6,761,000 | $4,879,000 |
| Exchange Rate Effect | N/A | -4,000 | 1,000 | 2,000 | -20,000 |
| Beginning Cash Position | 6,553,000 | 1,900,000 | 3,520,000 | 2,608,000 | 2,481,000 |
| End Cash Position | 8,408,000 | 4,295,000 | 1,900,000 | 3,520,000 | 2,459,000 |
| Net Cash Flow | $1,855,000 | $2,395,000 | $-1,620,000 | $912,000 | $-22,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,848,000 | 8,865,000 | 8,007,000 | 10,141,000 | 8,539,000 |
| Capital Expenditure | -2,457,000 | -2,037,000 | -1,918,000 | -2,224,000 | -2,367,000 |
| Free Cash Flow | 10,391,000 | 6,828,000 | 6,089,000 | 7,917,000 | 6,172,000 |